z-logo
open-access-imgOpen Access
Update on left ventricular hypertrophy
Author(s) -
C Jost,
Ch Attenhofer Jost
Publication year - 2005
Publication title -
kardiovask med
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 2
eISSN - 1662-629X
pISSN - 1423-5528
DOI - 10.4414/cvm.2005.01133
Subject(s) - left ventricular hypertrophy , cardiology , medicine , blood pressure
Summary Detection and evaluation of left ventricular hypertrophy of unknown etiology by echocardiography is important in every cardiology practice. Causes of left ventricular hypertrophy include sarcomeric protein disorders (classical hypertrophic cardiomyopathy), metabolic disease (glycogen storage disease including LAMP2 deficiency, PRKAG2 mutations, Fabry disease), syndromic hypertrophic cardiomyopathy (Noonan’s syndrome, LEOPARD syndrome, etc.) and miscellaneous causes including systemic hypertension, amyloidosis, athlete’s heart and pheochromocytoma. Although there are several echocardiographic changes quite typical for some of the disorders, most changes are not 100% specific. ECG findings and symptoms provide important additional information. Genetic testing is increasingly important. Nowadays, a combination of ECG findings, symptoms, family history, genetic testing and findings of echocardiography provide the best means for differentiation of left ventricular hypertrophy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom